Ocelot

Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions

Retrieved on: 
Thursday, March 7, 2024

This collaboration also provides Avinger the opportunity to distribute high-quality peripheral vascular products developed by Zylox-Tonbridge in the United States and Germany.

Key Points: 
  • This collaboration also provides Avinger the opportunity to distribute high-quality peripheral vascular products developed by Zylox-Tonbridge in the United States and Germany.
  • Avinger is globally recognized for its pioneering OCT-guided, catheter-based system and devices, offering real-time intra-vascular imaging during treatment.
  • By collaborating with Avinger, Zylox-Tonbridge is introducing the globally leading OCT-guided vascular treatment technology to the Chinese peripheral intervention market.
  • We believe this collaboration will expand the company's Peripheral Vascular Intervention product portfolio, reinforcing our market leadership, and accelerating the growth of the vessel preparation business in China's peripheral vascular intervention market.

SILVER ONE COMPLETES THE 100% ACQUISITION OF ITS PHOENIX SILVER PROJECT IN ARIZONA

Retrieved on: 
Thursday, February 8, 2024

Highlights of Phoenix Silver Project:

Key Points: 
  • Highlights of Phoenix Silver Project:
    Phoenix Silver Project covers 6,141 hectares along the northern extension of a prolific 30+km long mineralized trend hosting past and current producing silver and copper mines.
  • Greg Crowe, President and CEO of Silver One commented: "Acquiring a 100% interest in Phoenix Silver represents a rare opportunity in potentially identifying extremely rich silver vein mineralization.
  • Phoenix Silver lies at the northeast margin of a 30+ km long porphyry copper and silver belt and has excellent potential to host very high-grade silver mineralization as well as porphyry related copper mineralization."
  • In order to acquire a 100% interest in the Phoenix Silver Project, Silver One paid US$350,000 and issued ten million common shares of Silver One over 3 years to the property vendors.

SILVER ONE COMPLETES THE 100% ACQUISITION OF ITS PHOENIX SILVER PROJECT IN ARIZONA

Retrieved on: 
Thursday, February 8, 2024

Highlights of Phoenix Silver Project:

Key Points: 
  • Highlights of Phoenix Silver Project:
    Phoenix Silver Project covers 6,141 hectares along the northern extension of a prolific 30+km long mineralized trend hosting past and current producing silver and copper mines.
  • Greg Crowe, President and CEO of Silver One commented: "Acquiring a 100% interest in Phoenix Silver represents a rare opportunity in potentially identifying extremely rich silver vein mineralization.
  • Phoenix Silver lies at the northeast margin of a 30+ km long porphyry copper and silver belt and has excellent potential to host very high-grade silver mineralization as well as porphyry related copper mineralization."
  • In order to acquire a 100% interest in the Phoenix Silver Project, Silver One paid US$350,000 and issued ten million common shares of Silver One over 3 years to the property vendors.

Oscillot® Unveils Groundbreaking Plastic Cat-Proof Fence Roller - Affordable, Expansive Backyard Protection Now Available

Retrieved on: 
Wednesday, November 15, 2023

CHARLOTTE, N.C., Nov. 15, 2023 /PRNewswire/ -- Today, Oscillot®, a pioneer in cat containment solutions, is proud to announce a significant innovation in pet safety with their new plastic cat-proof fence roller. Building on eight successful years of manufacturing top-quality aluminum cat fence rollers, this new product offers an affordable and visually appealing alternative to traditional containment systems.

Key Points: 
  • Oscillot® combines safety with aesthetics in their new plastic cat fence roller, revolutionizing backyard cat containment.
  • CHARLOTTE, N.C., Nov. 15, 2023 /PRNewswire/ -- Today, Oscillot®, a pioneer in cat containment solutions, is proud to announce a significant innovation in pet safety with their new plastic cat-proof fence roller.
  • The new plastic rollers, available for preorder in North America and soon to be released in Australia, reflect Oscillot's dedication to quality, safety, and design.
  • Preorder or purchase the new Oscillot® plastic cat fence rollers today at https://oscillotamerica.com (North America), https://oscillot.eu (EU and UK), and join the revolution in cat containment and aesthetic design.

Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer

Retrieved on: 
Tuesday, April 18, 2023

Dr. Kjems succeeds founding chief scientific & medical officer, Stan Bukofzer, M.D., who will provide continued guidance to Ocelot Bio as a Strategic Advisor.

Key Points: 
  • Dr. Kjems succeeds founding chief scientific & medical officer, Stan Bukofzer, M.D., who will provide continued guidance to Ocelot Bio as a Strategic Advisor.
  • View the full release here: https://www.businesswire.com/news/home/20230418005491/en/
    Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer (Photo: Business Wire)
    “Dr.
  • “I am thrilled to welcome Dr. Kjems to the role of chief medical officer and am confident that her depth of experience leading successful clinical programs will add incredible value to the Ocelot Bio team.
  • Prior to joining Ocelot Bio, Dr. Kjems was the chief medical officer at Cyclo Therapeutics where she led its global program evaluating Trappsol® Cyclo™ in Alzheimer’s and rare disease.

Ocelot Expands SIS Interoperability with Ellucian Colleague Integration

Retrieved on: 
Thursday, March 23, 2023

SACRAMENTO, Calif., March 23, 2023 /PRNewswire/ -- Ocelot, the industry leader in AI communications purpose-built for higher education, today announced it will expand the flexibility of its solutions, adding integration capabilities for Ellucian Colleague. The Colleague integration enables more colleges and universities to access Ocelot's purpose-built AI, expansive content libraries, and network-based learning engine to deliver personalized student experiences that increase enrollment and retention. 

Key Points: 
  • SACRAMENTO, Calif., March 23, 2023 /PRNewswire/ -- Ocelot , the industry leader in AI communications purpose-built for higher education, today announced it will expand the flexibility of its solutions, adding integration capabilities for Ellucian Colleague.
  • Ellucian Colleague serves thousands of higher education institutions with its student information systems (SIS), finance and HR, recruiting, retention, analytics, and advancement software solutions.
  • Colleague is the latest in a growing list of SIS integrations for Ocelot, expanding the reach and flexibility of its purpose-built AI communications solutions.
  • "Ellucian Colleague is a natural integration for us with both our solutions and services deeply tailored to the unique needs of higher education," said Kelley Bradder, VP of Implementation and Product Support, Ocelot.

TendoNova Inks Partnership with AcCELLerated Biologics

Retrieved on: 
Wednesday, March 8, 2023

“The TendoNova Ocelot represents a great opportunity for improving the lives of over 30 million Americans affected by tendon pain,” said TendoNova CEO Mark A. Samuels.

Key Points: 
  • “The TendoNova Ocelot represents a great opportunity for improving the lives of over 30 million Americans affected by tendon pain,” said TendoNova CEO Mark A. Samuels.
  • “Our partnership with AcCELLerated Biologics will enable access to customers for their biologic products that are utilized adjacent to our Ocelot.”
    “For the past decade, AcCELLerated Biologics has been at the forefront of training and equipping physicians with new biologic tools useful in the treatment of a variety of injuries,” said AcCELLerated Biologics CEO Steve Whyte.
  • “Working with TendoNova allows us to expand our offering to help improve the surgical treatment that could be combined with biologics to produce positive outcomes.
  • TendoNova completed its manufacturing ramp-up in December 2022 and presently manufactures the Ocelot in Atlanta.

Ocelot Bio Presents Phase 1 Data Highlighting Activity and Safety of OCE-205 at AASLD The Liver Meeting®

Retrieved on: 
Friday, November 4, 2022

Across the dose range studied, OCE-205 serum levels (AUC and Cmax) were dose proportional.

Key Points: 
  • Across the dose range studied, OCE-205 serum levels (AUC and Cmax) were dose proportional.
  • The Phase 1 data presented at AASLD provide valuable information that will inform our clinical development strategy for OCE-205.
  • These data support further clinical development of OCE-205 as a potential treatment for conditions such as HRS-AKI and ascites.
  • Ocelot Bio is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics designed to significantly improve outcomes for patients with liver disease.

Ocelot Bio to Present Data Highlighting Pharmacodynamic Activity and Safety of OCE-205 at AASLD The Liver Meeting®

Retrieved on: 
Monday, October 24, 2022

We look forward to this opportunity to present, for the first time, data from our Phase 1 trial that underscores the potential of OCE-205 to address these limitations.

Key Points: 
  • We look forward to this opportunity to present, for the first time, data from our Phase 1 trial that underscores the potential of OCE-205 to address these limitations.
  • The full poster presentation will also be made available to registered meeting attendees via The Liver Meeting Digital Experience within 72 hours of presentation, and the poster will be available online at Ocelot Bios website.
  • The company has received Orphan Drug Designation for OCE-205 in the treatment of hepatorenal syndrome from the U.S. Food and Drug Administration.
  • Ocelot Bio is a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics designed to significantly improve outcomes for patients with liver disease.

Ocelot secures $117M investment to increase engagement between universities and students

Retrieved on: 
Wednesday, September 28, 2022

BOULDER, Colo., Sept. 28, 2022  /PRNewswire-PRWeb/ -- Ocelot, the leading edtech AI communications and student engagement platform, today announced it has raised $117 million from leading B2B software investment firm K1 Investment Management. The company was previously bootstrapped, with the K1 investment representing Ocelot's first outside funding. Funds from the investment will be used to fuel growth, build additional functionality within existing products, and develop new solutions for colleges and universities.

Key Points: 
  • A lack of engagement and communication is a recurring theme among these critical issues, according to both students and institutions.
  • Ocelot gives colleges and universities a unified engagement platform that easily integrates with existing technologies to offer students, staff, professors, and administrators a seamless communication experience.
  • According to research from EBA, 33% of first-gen students drop out within 3 years, compared to only 14% of continuing generation students.
  • Ocelot is higher education's #1 AI Communications and Student Engagement Platform, serving 8 million students at nearly 500 institutions.